Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities

Journal of Alzheimer's Disease

Volumn 40, Issue 2, 2014, Pages 399-408

  Dias, Irundika H K ^a   Polidori, Maria Cristina ^a,b,c   Li, Li ^a   Weber, Daniela ^d   Stahl, Wilhelm ^b   Nelles, Gereon ^e   Grune, Tilman ^d  

^a ASTON UNIVERSITY   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e NeuroMed MedCampus Hohenlind Cologne   (Germany)

Author keywords

3 nitrotyrosine; Aging; Alzheimer's disease; free radical scavenger; protein carbonyl formation; protein oxidation

Indexed keywords

CAROTENOID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; APOLIPOPROTEIN A1; TRITIUM;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL TRANSPORT; COGNITION; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NITRATION; OXIDATION; PRIORITY JOURNAL; BLOOD; DEMENTIA; GENETICS; METABOLISM; VASCULAR DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; TRITIUM; VASCULAR DISEASES;

EID: 84901952529     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131964     Document Type: Article

References (51)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, BaddourLM,Barker-Collo S, Bartels DH, BellML,Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, deVaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM,McAnulty JH, McDermottMM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R,Wilkinson JD,Woolf AD,Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128.
2. Ag?uero-Torres H kM, von Strauss E (2006) Rethinking the dementia diagnoses in a population-based study: What is Alzheimer's disease and what is vascular dementia? A study from the Kungsholmen Project. Dement Geriatr Cogn Disord 22, 244-249. (Pubitemid 44310521)
3. Bendlin BB, Carlsson CM, Gleason CE, Johnson SC, Sodhi A, Gallagher CL, Puglielli L, Engelman CD, Ries ML, Xu G, Wharton W, Asthana S (2010) Midlife predictors of Alzheimer's disease. Maturitas 65, 131-137.
4. Crean S,Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, Arrighi HM (2011) Apolipoprotein E epsilon4 prevalence in Alzheimer's disease patients varies across global populations:Asystematic literature reviewand meta-analysis. Dement Geriatr Cogn Disord 31, 20-30.
5. Xiao Z, Wang J, Chen W, Wang P, Zeng H, Chen W (2012) Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids Health Dis 11, 163.
6. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D,Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H,Warden D,Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ERLC, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JSK, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel K-H, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MMB, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues J-F, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43, 429-435.
7. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 377, 1019-1031.
8. Shepardson Ne SGMSDJ (2011) Cholesterol level and statin use in alzheimer disease: I. review of epidemiological and preclinical studies. Arch Neurol 68, 1239-1244.
9. Li L, Willets RS, Polidori MC, Stahl W, Nelles G, Sies H, Griffiths HR (2010) Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance. Free Radic Res 44, 241-248.
10. McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P (2013) Cochrane review on 'Statins for the treatment of dementia'. Int J Geriatr Psychiatry 28, 119-126.
11. Brown J, 3rd, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B (2004) Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem 279, 34674-34681. (Pubitemid 39318097)
12. Heverin M, Bogdanovic N, Lutjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, Bjorkhem I (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 45, 186-193. (Pubitemid 38180529)
13. Bjorkhem I (2006) Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 260, 493-508. (Pubitemid 44772369)
14. Zhong N, Weisgraber KH (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: Clues from its structure. J Biol Chem 284, 6027-6031.
15. Bodovitz S, Klein WL (1996) Cholesterol modulates alphasecretase cleavage of amyloid precursor protein. J Biol Chem 271, 4436-4440.
16. Zuliani G, Cavalieri M, Galvani M, Volpato S, Cherubini A, Bandinelli S, Corsi AM, Lauretani F, Guralnik JM, Fellin R, Ferrucci L (2010) Relationship between low levels of highdensity lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci 65, 559- 564.
17. Cuchel M, Rader DJ (2006) Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis? Circulation 113, 2548-2555. (Pubitemid 43948034)
18. Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, Koldamova R (2012) Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci 32, 13125- 13136.
19. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114, 529-541. (Pubitemid 39572103)
20. Zheng L, Settle M, Brubaker G, Schmitt D, Hazen SL, Smith JD, Kinter M (2005) Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem 280, 38-47. (Pubitemid 40164962)
21. Griffiths HR, Aldred S, Dale C, Nakano E, Kitas GD, Grant MG, Nugent D, Taiwo FA, Li L, Powers HJ (2006) Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake. Free Radic Biol Med 40, 488-500. (Pubitemid 43139684)
22. Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, Heinecke JW(2005) Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 280, 5983-5993. (Pubitemid 40280082)
23. Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW(2008) Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A 105, 12224- 12229.
24. PolidoriMC,Nelles G, PientkaL(2010) Prevention of dementia: Focus on lifestyle. Int J Alzheimers Dis 2010, pii: 393579.
25. Obulesu M, Dowlathabad MR, Bramhachari PV (2011) Carotenoids and Alzheimer's disease: An insight into therapeutic role of retinoids in animal models. Neurochem Int 59, 535-541.
26. Wang W, Shinto L, Connor WE, Quinn JF (2008) Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 13, 31-38. (Pubitemid 351365625)
27. Anlasik T, Sies H, Griffiths HR, Mecocci P, Stahl W, Polidori MC (2005) Dietary habits are major determinants of the plasma antioxidant status in healthy elderly subjects. Br J Nutr 94, 639-642. (Pubitemid 41672365)
28. R.S.P (1996) Absorption, metabolism and transport of carotenoids. FASEB J 10, 542-551.
29. Polidori MC, Mattioli P, Aldred S, Cecchetti R, StahlW, Griffiths H, Senin U, Sies H, Mecocci P (2004) Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: Relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord 18, 265-270. (Pubitemid 39370302)
30. Chung BH,Wilkinson T, Geer JC, Segrest JP (1980) Preparative and quantitative isolation of plasma lipoproteins: Rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 21, 284-291. (Pubitemid 10055505)
31. Weber D, Kneschke N, Grimm S, Bergheim I, Breusing N, Grune T (2012) Rapid and sensitive determination of proteinnitrotyrosine by ELISA: Application to human plasma. Free Radic Res 46, 276-285.
32. Stahl W, Schwarz W, Sundquist AR, Sies H (1992) cis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 294, 173-177.
33. Carty JL, Bevan R, Waller H, Mistry N, Cooke M, Lunec J, Griffiths HR (2000) The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 273, 729-735. (Pubitemid 30599052)
34. de la Torre J (2012) Preface: Physiopathology of vascular risk factors in Alzheimer's disease. J Alzheimers Dis 32, 517-518.
35. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG (2008) Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: The Whitehall II study. Arterioscler Thromb Vasc Biol 28, 1556-1562.
36. Balazs Z, Panzenboeck U, Hammer A, Sovic A, Quehenberger O, Malle E, Sattler W (2004) Uptake and transport of high-density lipoprotein (HDL) and HDL-associated -tocopherol by an in vitro blood-brain barrier model. J Neurochem 89, 939-950. (Pubitemid 38684741)
37. Umeda T, Mori H, Zheng H, Tomiyama T (2010) Regulation of cholesterol efflux by amyloid beta secretion. J Neurosci Res 88, 1985-1994.
38. Vickers KC, Remaley AT (2014) HDL and cholesterol: Life after the divorce? J Lipid Res 55, 4-12.
39. Clevidence BA, Bieri JG (1993) 4. Association of carotenoids with human plasma lipoproteins. In Methods in Enzymology, Lester P, ed. Academic Press, pp. 33-46.
40. Connor WE, Duell PB, Kean R, Wang Y (2007) The prime role of HDL to transport lutein into the retina: Evidence from HDL-deficientWHAMchicks having a mutantABCA1transporter. Invest Ophthalmol Vis Sci 48, 4226-4231. (Pubitemid 351261053)
41. Iizuka M, Ayaori M, Uto-Kondo H, Yakushiji E, Takiguchi S, Nakaya K, Hisada T, Sasaki M, Komatsu T, Yogo M, Kishimoto Y, Kondo K, Ikewaki K (2012) Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages. J Nutr Sci Vitaminol (Tokyo) 58, 96-104.
42. Palozza P, Catalano A, Simone RE, Mele MC, Cittadini A (2012) Effect of lycopene and tomato products on cholesterol metabolism. Ann Nutr Metab 61, 126-134.
43. Sies H, StahlW(1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62, 1315S- 1321S.
44. Fontana M, Blarzino C, Pecci L (2012) Formation of 3-nitrotyrosine by riboflavin photosensitized oxidation of tyrosine in the presence of nitrite. Amino Acids 42, 1857- 1865.
45. Graham DL, Carail M, Caris-Veyrat C, Lowe GM (2012) (13Z)- and (9Z)-lycopene isomers are major intermediates in the oxidative degradation of lycopene by cigarette smoke and Sin-1. Free Radic Res 46, 891-902.
46. PanasenkoOM, Briviba K, Klotz LO, SiesH(1997) Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch Biochem Biophys 343, 254-259. (Pubitemid 27297589)
47. Sigalov AB, Stern LJ (2001) Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Chem Physics Lipids 113, 133-146. (Pubitemid 33001482)
48. Wong YQ, Binger KJ, Howlett GJ, Griffin MDW (2010) Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. Proc Natl Acad Sci U S A 107, 1977-1982.
49. Khalil A, Berrougui H, Pawelec G, Fulop T (2012) Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease. Mech Ageing Dev 133, 20-29.
50. Tian L, Chen Y, Li C, Zeng Z, Xu Y, Long S, Fu M (2013) Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention. Lipids 48, 127-137.
51. Rubenfire M, Brook RD (2013) HDL cholesterol and cardiovascular outcomes: What is the evidence? Curr Cardiol Rep 15, 349.